Gland Pharma Limited has announced the appointment of Mr. Ajay Sahni as the new Chief Executive Officer of its wholly-owned subsidiary, Gland Pharma International Pte. Ltd. (Gland Singapore). This strategic appointment, effective from November 2, 2026, will see Mr. Sahni overseeing the Cenexi business, a step-down subsidiary. Mr. Sahni brings over 36 years of extensive experience in the FMCG and pharmaceutical industries, including significant leadership roles in international markets.
Leadership Transition at Gland Singapore
Gland Pharma Limited is pleased to announce the appointment of Mr. Ajay Sahni as the Chief Executive Officer of Gland Pharma International Pte. Ltd., its wholly-owned subsidiary. This strategic change in leadership is effective from November 2, 2026. Mr. Sahni will be instrumental in driving the growth and operations of Gland Singapore, reporting directly to the CEO of Gland Pharma Limited.
Responsibility for Cenexi Business
In his new role, Mr. Sahni will also assume responsibility for the Cenexi business, a wholly-owned step-down subsidiary of Gland Pharma Limited. His appointment marks a significant step in strengthening the management team and enhancing the company’s global strategic initiatives. The effective date for this additional responsibility is also November 2, 2026.
Experienced Leadership
Mr. Sahni possesses a rich professional background with over 36 years of experience in the FMCG and pharmaceutical sectors. His expertise spans financial management, business development, and general management. He has held senior positions such as Finance Director, Project Manager, Regional Finance Director, President, and Managing Director at various prominent companies, including Sanofi SA, Ferring Pharmaceuticals, and Wockhardt France SAS. Mr. Sahni has a proven track record of success in diverse international markets, including France, Belgium, Ireland, Switzerland, Singapore, and the USA. He holds a Bachelor’s degree in Business Administration from the European University of Brussels, Belgium.
Source: BSE
